Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$44.3M
3 rounds on record
Latest round
$15M
Venture round · May 2026 · 5 mo ago
Team
122
US Form 5500 (plan participants) · Dec 2025 · -10% in a year
The money's age
Fresh money
5 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 25 Launched Techcyte Launches Microsoft Teams Meetings from Fusion AP · jsonline.com May 1 Raised a round Venture round $15M · led by Van Tuyl Companies · Pulse 2.0 Mar 26 Recognition Techcyte Named 2025 Infectious Disease Testing Solution of the Year by BioTech Breakthrough Awards · freep.com Mar 23, 2025 Launched Techcyte Unveils Fusion, the First Unified Anatomic and Clinical Digital Pathology Platform · businesswire.com Dec 22, 2023 Raised a round Venture round $8.4M · SEC Form D Aug 18, 2021 Raised a round Venture round $20.9M · SEC Form D 2013 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round May 2026 $15M Van Tuyl Companies lead, Zoetis, Mayo Clinic Pulse 2.0
Venture round Dec 2023 $8.4M — SEC Form D
Venture round Aug 2021 $20.9M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Techcyte, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Richard SmithExecutive Officer, DirectorSEC Form D
Ben CahoonExecutive Officer, DirectorSEC Form D
Ralph YarroExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Mbr targeting. machine learning for user centric optimization.
Lantern uses cutting-edge machine learning to guide what, when, and how distributors buy.
PicoJool provides high-performance, energy-efficient data transmission solutions for AI and machine learning applications. Explore how they…
Liminal InsightsVenture round $10.1M · 2 yr ago • Founded 2016 • 51-200 employees
Unlock better battery insights for better batteries with Liminal’s ultrasound and machine learning inspection solutions. Elevate cell…
WeaveGridSeries B $35M · 3 yr ago • 51-200 employees • 3 roles
WeaveGrid enables utilities to manage load growth reliably and affordably through world-class software, machine learning, and data…
Firstlook AI builds PRISM, predictive intelligence for critical infrastructure. Built in Dallas by a team out of clinical machine learning…

Overview

Techcyte is an AI software platform for anatomic & clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients.

News

Blog 9 days ago
Techcyte Launches Microsoft Teams Meetings from Fusion AP
Facilitates live calls for frozen sections, consultations, and trainee reviewsTechcyte, developer of Fusion, the unified anatomic and clinical pathology AI platform, today announced a new Microsoft Teams enterprise integration that enables Microsoft Teams
Read more
Report
Blog 20 days ago
A Study Performed in the Microbiology Department of Vall d'Hebron University Hospital Shows High Agreement Between Manual Microscopy and Techcyte's AI for Ova and Parasite Testing.
Techcyte, a leader in AI-assisted digital microscopy, today announced the publication of a new peer-reviewed study in the Journal of Clinical Microbiology, one of the leading scientific journals on the subject, evaluating its fecal ova & parasite (O&P) de
Read more
Report
Blog 23 days ago
Aignostics Joins Techcyte Fusion Partner Program to Bring PathoSearch to Fusion AP
Techcyte, the developer of Fusion, the unified anatomic and clinical pathology AI platform, today announced that Aignostics has joined the Techcyte Fusion Partner Program. The companies have integrated Aignostics' PathoSearch application into Techcyte Fus
Read more
Report
Award 25 days ago
Techcyte Receives 2026 Innovation Award from Sonora Quest Laboratories
Techcyte, the leader in AI-powered digital microbiology, today announced that it has received the 2026 Innovation Award from Sonora Quest Laboratories during the organization's Strategic Supplier Summit.Techcyte was one of approximately 30 suppliers selec
Read more
Report
Blog 2 months ago
Techcyte Reorganizes Board of Directors to Support Next Phase of Growth
Techcyte, a leader in AI-powered digital pathology, today announced the reorganization of its Board of Directors to support the company's continued growth and mission to develop the leading digital pathology platform.Ralph Yarro, a Techcyte founder, will
Read more
Report
Blog 2 months ago
Techcyte and elea Bring AI-Native Pathology Reporting into Techcyte Fusion
The partnership brings elea's pathology-specific AI directly into Techcyte Fusion, enabling pathologists to turn diagnostic assessments into structured, coded reports within their existing digital workflow - going beyond transcription while keeping the pa
Read more
Report
Blog 2 months ago
Techcyte and Conflux Bring Transformative AI-Native Reporting to the Digital Pathology Workflow
OREM, Utah and SAN FRANCISCO, CaliforniaTechcyte, a leader in AI-powered digital pathology, and Conflux, a diagnostic intelligence company building AI-native workflows for pathology, today announced a partnership to integrate Conflux directly into the Tec
Read more
Report
Show more news

People

Richard Smith
Executive Officer, Director
Ben Cahoon
Executive Officer, Director
Ralph Yarro
Executive Officer, Director
Mohammed Salama
Director
Michael Wolfgramm
Director
Kent Gordon
Director
Kyle Wilson
Director
William Dorsey
Director
Michael Aicher
Director
Jay Tolley
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Orem United States
HQ
Mailing Address:
1-10 est. staff
Orem, UT 84057
company site

Financials

Total raised
$44.3M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $15M Details
Venture - Series Unknown 2023 $8.4M Details
Venture - Series Unknown 2021 $20.9M Details